Complementary effect of Roe's congenital heart disease treatment compared to Wade's

Published Date: 16 Feb 2023

As more states repeal or restrict abortion laws, the number of patients, the number of workers needed, and the cost of heart disease will increase. How should hospitals and policy makers prepare?

Read Full News

Latest News

When Self-Reflection Becomes a Physician’s Enemy

Medical training makes self-examination a core virtue. But for many physicians, a habit meant to promote growth can quietly curdle into something damaging.

Knowledge Areas: Transforming Hospital Care

Vall d’Hebron reorganized care into Knowledge Areas; the Heart Area pilot cut length of stay by 18%, 30-day readmissions by 12%, and in-hospital mortality by 48% — early but promising.

Extensive Screen Time Tied to CV Risk

Screen time is identified as an independent cardiovascular risk factor in an observational study of young adults living in Pakistan.

The Clinical Dilemma of Withholding Futile Treatment

When the ‘default’ is aggressive care, how do clinicians handle nonbeneficial treatment?

Long-Term Data Support Early SAVR in Severe Aortic Stenosis

At 10 years, early surgery continues to have a mortality benefit when compared with conservative care for asymptomatic aortic stenosis, according to long-term data from the RECOVERY trial.

Novel Wearable Detects Aortic Stenosis

A chest-worn biosensor that features several measurement signals in one device reliably identifies the presence and severity of aortic stenosis.

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Latest News

Medical training makes self-examination a core virtue. But for many physicians, a habit meant to promote growth can quietly curdle into something damaging.

Vall d’Hebron reorganized care into Knowledge Areas; the Heart Area pilot cut length of stay by 18%, 30-day readmissions by 12%, and in-hospital mortality by 48% — early but promising.

Screen time is identified as an independent cardiovascular risk factor in an observational study of young adults living in Pakistan.

When the ‘default’ is aggressive care, how do clinicians handle nonbeneficial treatment?

At 10 years, early surgery continues to have a mortality benefit when compared with conservative care for asymptomatic aortic stenosis, according to long-term data from the RECOVERY trial.

A chest-worn biosensor that features several measurement signals in one device reliably identifies the presence and severity of aortic stenosis.

News All Time

Inflammation May Explain Link Between Belly Fat, HF

Excess abdominal fat — not overall body weight — may drive heart failure risk, with systemic inflammation being partially to blame.

Arterial Stiffness Changes Linked to Developing Dementia

Pulse wave velocity, calculated from age and blood pressure changes, was associated with significant dementia risk in a post hoc SPRINT analysis.

In High-BP Patients, Lifestyle Tied to Cardiometabolic Risk

Maintaining a healthy lifestyle was associated with a lower risk for major cardiometabolic diseases, regardless of antihypertensive medication use.

Triple Agonist Retatrutide Reduces A1c, Weight in T2D

Eli Lilly and Company report top-line phase 3 clinical trial results for its investigational GLP-1, GIP, and glucagon agonist in people with type 2 diabetes.

Tool Spots Heart Failure Risk Missed in Patients With ASCVD

A risk model predicts the risk for heart failure in patients with atherosclerotic cardiovascular disease and flags a notable proportion classified as low risk by other risk tools.

Are Nursing Homes Misprescribing Antipsychotics?

The HHS Inspector General claims that some nursing homes are inappropriately diagnosing residents with schizophrenia and prescribing antipsychotics without proper oversight.

CAC Still Predicts Heart Risk When Lp(a) Is High

An observational study shows the two factors to be independent predictors of atherosclerotic cardiovascular disease.

Is ‘Good’ Cholesterol Really Good? HDL Role Evolving

Both low and extremely high HDL cholesterol levels may increase cardiovascular risk.

Light Activity May Reduce HBP Risk in Pregnancy

No need for strenuous exercise: Consistent, daily light activity can reduce hypertension risk in pregnant women by 30%.

High Blood Pressure Is Risky, Even for Young Adults

Young adults with systolic blood pressure that is 10 points higher than that of their peers have a 27% greater risk for heart disease and a 22% greater risk for kidney disease after age 40.

Premature Menopause Linked With Greater Risk for CHD

Menopause before age 40 is correlated with a much greater risk for coronary heart disease, and therefore cardiologists should consider earlier preventive measures for this population.

HIV Status Affects Pregnancy-Related Cardiac Changes

Pregnancy history is associated with significant differences in cardiac structure and function, which vary by HIV status.

Match Day 2026: Is Family Medicine Half-Full or Half-Empty?

As medical students learn where they’ll spend their residencies, it’s clear they’re gravitating toward programs in higher-paying fields or those offering more work-life balance.

Women With Metabolic Risks More Prone to Liver Fibrosis

Women with certain cardiometabolic risk factors face a disproportionately greater increase in the odds of clinically significant liver fibrosis than men.

CSP vs BiV Pacing Trials Show Inconsistent Results

Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for left bundle branch block in heart failure.

PREVENT Score Alters Hypertension Treatment Over 65

A new analysis shows the 2025 hypertension guideline’s risk-based framework spares a small subgroup from immediate treatment.

Recommended News For You

An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.

AI innovation unlocks non-surgical way to detect brain cancer spread

Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

Don't Call It Cancer; Clues to 'Exceptional' Responses; More Predictions for 2025

Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type

Recommended Articles For You

Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies 

Unlocking the Power of Cryoprecipitate: A Comprehensive Guide 

Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights 

Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Novel Agent for Chronic GVHD Wins FDA Approval

2.

According to the Lancet, having cancer and VTE at the same time increases mortality risk.

3.

Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.

4.

New research demonstrates a method for screening people at high risk for pancreatic cancer.

5.

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

1.

Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy

2.

Next-Gen Cancer Therapies: Radiopharmaceuticals, Immuno-Oncology, and Biologic Breakthroughs

3.

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

4.

HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians

5.

The benefits and risks of taking fludrocortisone for adrenal insufficiency 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

2.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III

4.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

5.

Efficient Management of First line ALK-rearranged NSCLC - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot